来自人类的柔毛短螺旋体分离株的体外抗菌药敏性
In vitro antimicrobial susceptibility of Brachyspira pilosicoli isolates from humans.
作者信息
Brooke C J, Hampson D J, Riley T V
机构信息
Division of Veterinary and Biomedical Sciences, Murdoch University, Murdoch, Western Australia 6150, Australia.
出版信息
Antimicrob Agents Chemother. 2003 Jul;47(7):2354-7. doi: 10.1128/AAC.47.7.2354-2357.2003.
Abstract
The in vitro antimicrobial susceptibility of the anaerobic intestinal spirochete Brachyspira pilosicoli was investigated by an agar dilution method. Human (n = 123) and porcine (n = 16) isolates were susceptible to metronidazole, ceftriaxone, meropenem, tetracycline, moxifloxacin, and chloramphenicol; erythromycin and ciprofloxacin were not active. Resistance to amoxicillin and clindamycin varied. Amoxicillin susceptibility was restored by clavulanic acid.
摘要
采用琼脂稀释法研究了厌氧肠道螺旋体短螺旋体的体外抗菌药敏性。人源（n = 123）和猪源（n = 16）分离株对甲硝唑、头孢曲松、美罗培南、四环素、莫西沙星和氯霉素敏感；红霉素和环丙沙星无活性。对阿莫西林和克林霉素的耐药性各不相同。克拉维酸可恢复阿莫西林的敏感性。
相似文献
1
In vitro antimicrobial susceptibility of Brachyspira pilosicoli isolates from humans.
Antimicrob Agents Chemother. 2003 Jul;47(7):2354-7. doi: 10.1128/AAC.47.7.2354-2357.2003.
2
Susceptibilities of Campylobacter jejuni isolates from Germany to ciprofloxacin, moxifloxacin, erythromycin, clindamycin, and tetracycline.
Antimicrob Agents Chemother. 2003 Jul;47(7):2358-61. doi: 10.1128/AAC.47.7.2358-2361.2003.
3
Antimicrobial susceptibility testing of Brachyspira intermedia and Brachyspira pilosicoli isolates from Australian chickens.
Avian Pathol. 2006 Feb;35(1):12-6. doi: 10.1080/03079450500465643.
4
Minimal inhibitory concentrations and time-kill determination of moxifloxacin against aerobic and anaerobic isolates.
Int J Antimicrob Agents. 2002 Feb;19(2):111-8. doi: 10.1016/s0924-8579(01)00486-1.
5
[Antimicrobial Susceptibility of Pathogenic Gram-positive Anaerobic Cocci: Data of a University Hospital in Turkey].
Mikrobiyol Bul. 2020 Jul;54(3):404-417. doi: 10.5578/mb.69556.
6
Antianaerobic activity of moxifloxacin compared with that of ofloxacin, ciprofloxacin, clindamycin, metronidazole and beta-lactams.
Int J Antimicrob Agents. 2002 Nov;20(5):366-74. doi: 10.1016/s0924-8579(02)00209-1.
7
Comparative in vitro activity of BAY 12-8039 and five other antimicrobial agents against anaerobic bacteria.
Eur J Clin Microbiol Infect Dis. 1998 Mar;17(3):193-5. doi: 10.1007/BF01691117.
8
In vitro activity of ceftaroline against a broad spectrum of recent clinical anaerobic isolates.
Antimicrob Agents Chemother. 2011 Jan;55(1):421-5. doi: 10.1128/AAC.00868-10. Epub 2010 Nov 1.
9
Tiamulin resistance in porcine Brachyspira pilosicoli isolates.
Res Vet Sci. 2006 Feb;80(1):1-4. doi: 10.1016/j.rvsc.2005.02.004. Epub 2005 Apr 2.
10
Susceptibility of oral obligate anaerobes to telithromycin, moxifloxacin and a number of commonly used antibacterials.
Oral Microbiol Immunol. 2007 Oct;22(5):298-303. doi: 10.1111/j.1399-302X.2007.00359.x.
引用本文的文献
1
Colonizing the Unlikely: in an Immunocompetent Patient.
ACG Case Rep J. 2024 Apr 18;11(4):e01338. doi: 10.14309/crj.0000000000001338. eCollection 2024 Apr.
2
Brushing Up on Brush Borders: Intestinal Spirochetosis Diagnosis and Management.
Kans J Med. 2021 Nov 5;14(3):290-291. doi: 10.17161/kjm.vol14.15535. eCollection 2021.
3
Distribution of Flumequine in Intestinal Contents and Colon Tissue in Pigs after Its Therapeutic Use in the Drinking Water.
Animals (Basel). 2021 May 23;11(6):1514. doi: 10.3390/ani11061514.
4
Answer to February 2021 Photo Quiz.
J Clin Microbiol. 2021 Jan 21;59(2). doi: 10.1128/JCM.00401-20.
5
The Spirochete Brachyspira pilosicoli, Enteric Pathogen of Animals and Humans.
Clin Microbiol Rev. 2017 Nov 29;31(1). doi: 10.1128/CMR.00087-17. Print 2018 Jan.
6
Intestinal spirochetosis mimicking inflammatory bowel disease in children.
BMC Pediatr. 2012 Oct 16;12:163. doi: 10.1186/1471-2431-12-163.
7
Bloodstream infection due to Brachyspira pilosicoli in a patient with multiorgan failure.
J Clin Microbiol. 2011 Oct;49(10):3697-9. doi: 10.1128/JCM.00680-11. Epub 2011 Aug 10.
8
Human intestinal spirochetosis--a review.
Ger Med Sci. 2010 Jan 7;8:Doc01. doi: 10.3205/000090.
9
Brachyspira pilosicoli bloodstream infections: case report and review of the literature.
Ann Clin Microbiol Antimicrob. 2008 Sep 25;7:19. doi: 10.1186/1476-0711-7-19.
10
Genetic and biochemical characterization of OXA-63, a new class D beta-lactamase from Brachyspira pilosicoli BM4442.
Antimicrob Agents Chemother. 2008 Apr;52(4):1264-8. doi: 10.1128/AAC.00684-07. Epub 2008 Jan 22.
本文引用的文献
1
Brachyspira (Serpulina) pilosicoli spirochetemia in an immunocompromised patient.
Infection. 2002 Jun;30(3):175-7. doi: 10.1007/s15010-002-2175-1.
2
Carriage of intestinal spirochaetes by humans: epidemiological data from Western Australia.
Epidemiol Infect. 2001 Oct;127(2):369-74. doi: 10.1017/s095026880100588x.
3
Comparative prevalences of Brachyspira aalborgi and Brachyspira (Serpulina) pilosicoli as etiologic agents of histologically identified intestinal spirochetosis in Australia.
J Clin Microbiol. 2001 Jan;39(1):347-50. doi: 10.1128/JCM.39.1.347-350.2001.
4
Comparative in vitro activities of GAR-936 against aerobic and anaerobic animal and human bite wound pathogens.
Antimicrob Agents Chemother. 2000 Oct;44(10):2747-51. doi: 10.1128/AAC.44.10.2747-2751.2000.
5
Comparative in vitro activities of clinafloxacin and trovafloxacin against 1,000 isolates of bacteroides fragilis group: effect of the medium on test results.
Antimicrob Agents Chemother. 2000 Jun;44(6):1710-2. doi: 10.1128/AAC.44.6.1710-1712.2000.
6
Otitis media in Australian Aboriginal children: an overview.
Int J Pediatr Otorhinolaryngol. 1999 Oct 5;49 Suppl 1:S173-8. doi: 10.1016/s0165-5876(99)00156-1.
7
Genetic basis of macrolide and lincosamide resistance in Brachyspira (Serpulina) hyodysenteriae.
FEMS Microbiol Lett. 1999 Mar 15;172(2):255-60. doi: 10.1111/j.1574-6968.1999.tb13476.x.
8
In vitro activity of four antimicrobial agents against North American isolates of porcine Serpulina pilosicoli.
J Vet Diagn Invest. 1998 Oct;10(4):350-6. doi: 10.1177/104063879801000407.
9
The prevalence of Serpulina pilosicoli in humans and domestic animals in the Eastern Highlands of Papua New Guinea.
Epidemiol Infect. 1997 Dec;119(3):369-79. doi: 10.1017/s0950268897008194.
10
Isolation of Serpulina pilosicoli from rectal biopsy specimens showing evidence of intestinal spirochetosis.
J Clin Microbiol. 1998 Jan;36(1):261-5. doi: 10.1128/JCM.36.1.261-265.1998.
Zotero 插件